President Donald Trump announced a new deal to make fertility treatments and medications far more affordable for American families, a move that immediately undercut one of the Democrats’ biggest talking points.

Speaking from the Oval Office, Trump said his administration reached an agreement with EMD Serono, the world’s largest fertility drug manufacturer, to deliver “massive discounts” on its products sold in the United States.

The deal is part of the administration’s broader effort to lower the cost of medical care and medicines nationwide — one of Trump’s key policy priorities since returning to office.

He began the announcement by thanking his Cabinet, including Health and Human Services Secretary Robert F. Kennedy Jr., then joked about Kennedy’s wife, actress Cheryl Hines, after her appearance on “The View.”

“I’m never going to get into an argument with her!” Trump said, drawing laughs before turning serious.

“After extensive negotiations, EMD Serono has agreed to provide massive discounts on fertility products in the U.S.,” Trump said.

He added that the company also agreed to give “Most Favored Nation” pricing on future pharmaceuticals sold in America, meaning no other country will get better rates than U.S. patients.

The announcement followed similar deals earlier this month with major pharmaceutical firms that also agreed to lower prices on widely used drugs, including those covered by Medicare.

Senator Katie Britt of Alabama praised the IVF deal as a “game changer” for families struggling with infertility.

EMD Serono’s Senior Vice President of U.S. Fertility and Endocrinology thanked the administration for making good on its promises to the American people.

“This president delivered on his promise to the American people,” the company executive said.

Trump also revealed that the plan includes expanded insurance options for infertility treatments through employer coverage, a move aimed at making these medical services accessible to more working Americans.

When Trump invited Robert F. Kennedy Jr. to speak, the health secretary credited the deal to the administration’s Make America Healthy Again (MAHA) agenda.

Kennedy said part of the administration’s research effort has focused on studying endocrine disruptors — chemicals linked to modern infertility — as part of a broader campaign to improve family health.

Kennedy thanked Trump for his leadership, saying his focus on restoring health and affordability “is exactly what families across this country have been waiting for.”

Trump responded with his trademark humor, referencing his recent remark after the Israel-Hamas peace deal, when he joked about whether he’d ever “get to Heaven.”

The moment lightened the room, but the significance of the policy shift was clear. The administration’s direct engagement with pharmaceutical companies has already led to steep price reductions in several categories — from heart medication to diabetes treatments, and now fertility drugs.

By tackling both cost and access at once, Trump’s move neutralized months of Democratic attacks claiming his administration was indifferent to reproductive health issues.

The White House said more details will be released soon as the plan expands to additional companies and insurers.

Trump ended the announcement by saying that “families deserve real options, not inflated prices.”

With this new agreement, the administration positioned itself as the first to bring significant cost relief to couples struggling with infertility — and in doing so, completely turned the Democrats’ narrative on its head.